List of Contents
What is Closed System Transfer Device Market Size?
The global closed system transfer device market size accounted for USD 1.57 billion in 2025 and is predicted to reach around USD 3.66 billion by 2034, growing at a CAGR of 9.84% from 2025 to 2034.
Market Highlights
- North America led the global market with the highest market share in 2024.
- By Type, the membrane-to-membrane systems segment had the biggest market share in 2024.
- By Closing Mechanism, the push-to-turn systems segment is estimated to hold the highest market share in 2024.
- By End User, the hospitals segment has held the largest revenue share in 2024.
Market Size and Forecast
- Market Size in 2025: USD 1.57 Billion
- Market Size in 2026: USD 1.73 Billion
- Forecasted Market Size by 2034: USD 3.66 Billion
- CAGR (2025-2034): 9.84%
- Largest Market in 2024: North America
- Fastest Growing Market: Asia Pacific
Growth Factors
- Increasing prevalence of cancer
- Growing need for regulatory compliance for the safe handling of harmful drugs
- Rising adoption of closed-system transfer devices for transferring hazardous drugs
- Increasing use of CSTDs in emerging markets
Forecasting Safety: Market Outlook
- Industry Growth Overview: Growing awareness, stringent regulations, and increasing cancer incidences are contributing to the industrial growth in the market.
- Major Investors:Large healthcare and medical device corporations and private equity firms are the major investors in the market. ICU Medical, Inc., Baxter International, and B. Braun Melsungen AG are some of the major investors.
- Startup Ecosystem: The startup ecosystem is focusing on enhancing the usability, compatibility with different drug delivery systems, integration with advanced technologies, and reducing drug waste of the closed system transfer device
Market Scope
| Report Highlights | Details |
| Market Size in 2025 | USD 1.57 Billion |
| Market Size in 2026 | USD 1.73 Billion |
| Market Size by 2034 | USD 3.66 Billion |
| Growth Rate from 2025to 2034 | CAGR of 9.84% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025to 2034 |
| Segments Covered | Type, Component, End User, Closing Mechanism, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segment Insights
Type Insights
Membrane-to-Membrane Systems Segment Seized Foremost Market Stake in 2024
Membrane-to-Membrane Systems segment recorded the prime market share in the global closed-system transfer device Market in 2024. The membrane-to-membrane transference devices use the dual membrane system among the syringe and vial further supports to isolate the medical preparation. The factors such as reduced contamination risk, and ease of usage of the double-membrane systems confirm the safety expected to increase the usage of the membrane-to-membrane transmission devices over the estimated period.
The needleless systems are projected to grow at the highest CAGR during the forecast period mainly due to benefits such as needle-free transmission of drugs. Moreover, new product launches are expected to contribute to the high growth of needleless systems.
Closing Mechanism Insights
Push-To-Turn Systems Projected to Rulethe Closing Mechanism Segment of Closed System Transfer Device Market Revenue
Closed system transfer devices are rapidly being employed for the safe transfer of harmful medical preparations. High research and development activity in closed-system transfer devices for the transfer of oncology medications is the major reason for the high revenue share of closed-system transfer devices.
The luer-lock systems segment will expand at the highest CAGR during the forecast time frame.
End User Insights
Hospitals Projected to Dominate the End-User Segment of Closed System Transfer Device Market Revenue
Hospitals have the funds to procure expensive closed-system transfer devices that help in the safe transfer of hazardous medical preparations when compared to small clinics and oncology centers.
Regional Insights
U.S. Closed System Transfer Device Market Size and Growth 2025To 2034
The U.S. closed system transfer device market size is valued at USD 540 million in 2025 and is expected to be worth USD 1,260 million by 2034, at a CAGR of 10% from 2025 to 2034.
Regulations Propelling the U.S Market
The presence of robust regulations and the healthcare system is increasing the use of the closed system transfer device in the U.S. At the same time, the growing incidences of cancer are increasing their use, where the industries are also focusing on enhancing the systems, which are driving their innovations.
North America is Estimated to be the Largest Market for Closed System Transfer Device
The research report covers key trends and prospects of closed system transfer device products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, the closed system transfer device market is conquered by North America owing to a high incidence of cancer and the presence of a sophisticated healthcare framework. On the other hand, Asia-Pacific is anticipated to witness a rapid growth rate, on account of increasing healthcare expenditure and growing investment by major manufacturers to launch new products.
Rising Cancer Burden Powering Asia Pacific Healthcare
Asia Pacific is expected to host the fastest-growing closed system transfer device market during the forecast period, driven by increasing cancer incidences. The expanding healthcare is increasing its adoption, where the growing awareness is also encouraging its use. To comply with the regulation of safe drug-compounding practice, its use is increasing.
Expanding Oncology Sector Fuels India
The growing oncology sector in India is increasing the adoption and use of closed system transfer devices. Moreover, growing cancer cases and safety awareness are also increasing their use. The government investments are also supporting their adoption.
Safet Compliance Leads Europe
Europe is expected to grow significantly in the closed system transfer device market during the forecast period, as stringent regulations with robust safety standards are increasing the use. Moreover, advanced healthcare and increasing healthcare investments are increasing their utilization. The companies are collaborating to develop new such systems, promoting the market growth.
Safety Awareness: Transform the UK market
The UK is driven by growth in health awareness, with the increasing use of closed system transfer devices for safety purposes. The growing cancer burdens and government initiatives are enhancing their adoption rates, where the industries are also contributing to these advancements.
Strengthening Safety: Value Chain Analysis
- R&D
The R&D of the closed system transfer device is focused on the integration of physical CSTD products with pharmacy automation to streamline compounding workflows, with enhanced compatibility and safety of the devices.
Key players: ICU Medical, Inc., Equashield, and Braun Melsungen.
- Clinical Trials and Regulatory Approvals
The clinical trial and regulatory approval of the closed system transfer device involve the performance, safety, and compatibility evaluation.
Key players: NIOSH, ICU Medical, Inc., Equashield
- Healthcare Workers Support and Services
Extensive clinical education, technical support, and training programs are provided to the healthcare workers in support and services of the closed system transfer device.
Key players: ICU Medical, Inc., Braun Melsungen.
Key Players in Closed System Transfer Devices Market and Their Offerings
- Becton, Dickinson, and Company: The company provides products like PhaSeal System, PhaSeal Optima System, and Texium.
- ICU Medical, Inc.: Devices such as the ChemoLock system, ChemoClave system are provided by the company.
- Braun Melsungen: The company offers OnGuard with Tevadaptor
- Equashield: Equashield II, Equashield Pro are offered by the company.
- Corvida Medical:The HALO System is provided by the company
Segment Covered in the Report
By Type
- Needleless Systems
- Membrane-to-Membrane Systems
By Closing Mechanism
- Color-To-Color Alignment Systems
- Push-To-Turn Systems
- Click-To-Lock Systems
- Luer-Lock Systems
By Component
- Syringe Safety Devices
- Vial Access Devices
- Accessories
- Bag/Line Access Devices
By End User
- Clinics & Oncology Centers
- Hospitals
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client